PT - JOURNAL ARTICLE AU - Farajidavar, Nazli AU - O’Gallagher, Kevin AU - Bean, Daniel AU - Nabeebaccus, Adam AU - Zakeri, Rosita AU - Bromage, Daniel AU - Kraljevic, Zeljko AU - Teo, James TH AU - Dobson, Richard J AU - Shah, Ajay M TI - Diagnostic signature for Heart Failure with Preserved Ejection Fraction (HFpEF): A Machine Learning Approach Using Multi-Modality Electronic Health Record Data AID - 10.1101/2021.11.18.21266560 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.18.21266560 4099 - http://medrxiv.org/content/early/2021/11/19/2021.11.18.21266560.short 4100 - http://medrxiv.org/content/early/2021/11/19/2021.11.18.21266560.full AB - Aims Heart failure with preserved ejection fraction (HFpEF) is thought to be highly prevalent yet remains underdiagnosed. We sought to develop a data-driven diagnostic model to predict from electronic health records (EHR) the likelihood of HFpEF among patients with unexplained dyspnea and preserved left ventricular EF.Methods & Results The derivation cohort comprised patients with dyspnea and echocardiography results. Structured and unstructured data were extracted using an automated informatics pipeline. Patients were retrospectively diagnosed as HFpEF (cases), non-HF (control cohort I), or HF with reduced EF (HFrEF; control cohort II). The ability of clinical parameters and investigations to discriminate cases from controls was evaluated by extreme gradient boosting. A likelihood scoring system was developed and validated in a separate test cohort.The derivation cohort included 1585 consecutive patients: 133 cases of HFpEF (9%), 194 non-HF cases (Control cohort I) and 1258 HFrEF cases (Control cohort II). Two HFpEF diagnostic signatures were derived, comprising symptoms, diagnoses and investigation results. A final prediction model was generated based on the averaged likelihood scores from these two models. In a validation cohort consisting of 269 consecutive patients (with 66 HFpEF cases (24.5%)), the diagnostic power of detecting HFpEF had an AUROC of 90% (P<0.001) and average precision (AP) of 74%.Conclusion This diagnostic signature enables discrimination of HFpEF from non-cardiac dyspnea or HFrEF from EHR and can assist in the diagnostic evaluation in patients with unexplained dyspnea.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the British Heart Foundation (RE/18/2/34213; CH/1999001/11735); the NIHR Biomedical Research Centres at Guys & St Thomas NHS Foundation Trust (IS-BRC-1215-20006) and South London and Maudsley NHS Foundation Trust (IS-BRC-1215-20018), both with Kings College London. KOG is supported by a Medical Research Council Clinical Training Fellowship (MR/R017751/1). DMB is funded by a UKRI Innovation Fellowship as part of Health Data Research UK MR/S00310X/1 (https://www.hdruk.ac.uk). The views expressed are those of the authors and not necessarily those of NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was conducted under London South East Research Ethics Committee approval (reference 18/LO/2048) granted to the Kings Electronic Records Research Interface (KERRI), project ID 202020201.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data included in the study will not be made available to other researchers due to hospital information governance regulations. However, we will share our models and the analytical methods to facilitate the replication of the study on data collected from other hospitals.